Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy. (Q35591583)
Jump to navigation
Jump to search
scientific article published on 31 March 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy. |
scientific article published on 31 March 2015 |
Statements
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy (English)
Yi-Long Wu
Jin Soo Lee
Virote Sriuranpong
Jennifer Sandoval-Tan
Guia Ladrera
Sumitra Thongprasert
Vichien Srimuninnimit
Meilin Liao
Yunzhong Zhu
Caicun Zhou
Fatima Fuerte
Benjamin Margono
Wei Wen
Julie Tsai
Matt Truman
Barbara Klughammer
David S Shames